Kurtz Ronald M MD 4
4 · RxSight, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Kurtz Ronald M MD
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-01-08$43.50/sh−31,250$1,359,375→ 835,860 total(indirect: See footnote) - Sale
Common Stock
2024-01-08$45.00/sh−31,250$1,406,256→ 804,610 total(indirect: See footnote)
Holdings
- 40,000
Common Stock
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person.
- [F2]Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
- [F3]Represents the weighted average share price of an aggregate total of 31,250 shares sold in the price range of $45.00 to $45.02 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.